Mark Ahn, PhD is an academic with over 50 publications on topics ranging from project management to biopharmaceutical innovation and commercialization. Throughout his career in biotechnology he has continued his education both as a student and a professor. He has also leveraged his knowledge and experience in business in advisory and board roles for both startups and large companies.
Mark Ahn received a BA and MBA from Chaminade University in Hawaii, a Rotary International Graduate Fellowship in Economics for the University of Essex, an MA in Classics from Victoria University, and a PhD in Business Administration from the University of South Australia where he did his dissertation on, Enhancing Strategic Management for Multinational Pharmaceutical Companies in China.
Dr. Ahn is the author of over 50 peer reviewed journal articles and books, including Building the Case for Biotechnology. His numerous works have generally related to innovation, entrepreneurship and life sciences have been published in many peer reviewed journals and books. Ahn currently sits on the board of various startup and established companies including Plasmtech and Immusoft.
Ahn has taught at a number of well respected academic institutions all across the world. At Victoria University, Ahn taught Science & Technology Entrepreneurship with a joint appointment from the faculties of Commerce & Administration and Science, until moving his family to Portland where he now teaches as an adjunct professor at Portland State University and Carnegie Mellon.